Durability of HBeAg Seroconversion of Telbivudine as Monotherapy and as Combination Therapy with Ade

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:chrisevenk
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:The EFFORT study have concluded that adjusting treatment strategy is recommended for suboptimal virological responders to telbivudine(LdT) at week 24,adding on adefovir(ADV) can benefit these patients with additive antiviral potency for HBeAg positive chronic hepatitis B(CHB) patients.
其他文献
Background:Effects of caloric supplementation on the graft function after deceased donor liver transplantation(DDLT) have not been investigated much.
会议
AIM:To investigate effect of LOXL2 on progression and metastasis of hepatocellular carcinoma(HCC) when LOXL2 silenced in HCC cells.
会议
Background:In clinical settings,it is difficult to discern the patients in immune reactive phase from the patients in immune tolerant phase when patients show marginal AST/ALT elevation.
会议
Background:IRE1,hallmark of endoplasmic reticular stress,has been previously shown as a prosurvival molecule in cancer therapy by multikinase inhibitor sorafenib.
会议
Background:Gamma delta T cells play an important role in infectious,autoimmune,or neoplastic diseases.Our previous studies have found that the proportion of gamma delta T cells increased with abnormal
会议
Background:To study the function of TH1/TH2 types cell in chronic hepatitis B(CHB)patients during the treatment by autologous cytokine-induced kill cells combined with nucleoside(acid) analogues of an
会议
Background:5 %-10 %Hepatitis B vaccinees produce an inadequate neutralizing antibody response following receipt of the standard vaccination regime.Genetic predisposition has been discovered to be one
会议
Background:Genetic studies have been conducted to investigate host susceptibility of the hepatitis B virus(HBV) infection;SNPs in the HLA region(6p21) were mostly reported associated with the disease
会议
Background:We investigated whether the concept of virologic breakthrough suggested by current guidelines or literatures is appropriate for treatment with entecavir(ETV) in the era of sensitive HBV DNA
会议
Background:An important goal in the treatment of chronic hepatitis B virus(HBV) infection is to prevent hepatocellular carcinoma and liver cirrhosis by suppressing HBV replication.
会议